Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Hum Immunol ; 81(4): 186-190, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31733925

RESUMEN

Human leukocyte antigen (HLA)-G, a non-classical HLA class I molecule, has one of the splicing isoforms, HLA-G2, which lacks one domain (α2) and forms a non-covalent homodimer. HLA-G2 is expressed on placental cells, regulatory T cells, tumor cells, and virus-infected cells, and is involved in immunosuppression. The major isoform of HLA-G, HLA-G1, binds to leukocyte immunoglobulin (Ig)-like receptor (LILR) B1 and LILRB2, on the contrary, HLA-G2 binds to only LILRB2. We previously reported that HLA-G2 bound LILRB2 more strongly than HLA-G1 and also to paired Ig-like receptor (PIR)-B, a mouse homolog of LILRBs. Furthermore, HLA-G2 showed immunosuppressive effects in both collagen-induced arthritis (CIA) and atopic dermatitis-like model mice. In this study, we examine in vivo effects of HLA-G2 in systemic lupus erythematosus (SLE) model mice. HLA-G2 showed the suppression of the typical SLE symptoms such as serum anti-dsDNA antibody level and urinary albumin index. Furthermore, HLA-G2 tended to downregulate B-lymphocyte stimulator (BLyS) production. This is the first observation of the immunosuppressive effects of HLA-G2 isoform in SLE model mice, suggesting that HLA-G2 could be a useful therapeutic agent for SLE.


Asunto(s)
Antígenos HLA-G/administración & dosificación , Lupus Eritematoso Sistémico/tratamiento farmacológico , Albúminas/análisis , Animales , Autoanticuerpos/sangre , Factor Activador de Células B/sangre , Modelos Animales de Enfermedad , Femenino , Humanos , Inyecciones Intraperitoneales , Lupus Eritematoso Sistémico/inmunología , Ratones , Ratones Endogámicos MRL lpr , Proteínas Recombinantes/administración & dosificación , Resultado del Tratamiento
2.
Nat Commun ; 4: 2303, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23941973

RESUMEN

Understanding how climate warming has an impact on the life cycle schedule of terrestrial organisms is critical to evaluate ecosystem vulnerability to environmental change. Despite recent advances identifying the molecular basis of temperature responses, few studies have incorporated this knowledge into predictive models. Here we develop a method to forecast flowering phenology by modelling regulatory dynamics of key flowering-time genes in perennial life cycles. The model, parameterized by controlled laboratory experiments, accurately reproduces the seasonal changes in gene expression, the corresponding timing of floral initiation and return to vegetative growth after a period of flowering in complex natural environments. A striking scenario forecast by the model under climate warming is that the shift in the return time to vegetative growth is greater than that in floral initiation, which results in a significant reduction of the flowering period. Our study demonstrates the usefulness of gene expression assessment to predict unexplored risks of climate change.


Asunto(s)
Arabidopsis/crecimiento & desarrollo , Arabidopsis/fisiología , Cambio Climático , Flores/crecimiento & desarrollo , Animales , Arabidopsis/genética , Flores/genética , Perfilación de la Expresión Génica , Estadios del Ciclo de Vida/genética , Estadios del Ciclo de Vida/fisiología , Modelos Teóricos , Datos de Secuencia Molecular , Fotoperiodo , Estaciones del Año , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...